Related Experiment Video
Updated: Jul 9, 2025

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
A Pediatric Patient with Severe Obstructive Sleep Apnea and Comorbid Depression and Substance Abuse
Caitlin E Leconte1, Joshua W Ng2, Ann M Manzardo3
1University of Kansas School of Medicine, 2060 W 39th Avenue, Kansas City, KS 66103, USA.
Insights
Obstructive sleep apnea (OSA) is often missed in adolescents with depression and substance abuse. Treating OSA significantly improved these psychiatric symptoms, highlighting the importance of screening for sleep apnea.
Area of Science:
- Sleep Medicine
- Psychiatry
- Adolescent Health
Background:
- Obstructive sleep apnea (OSA), depression, and substance abuse share overlapping symptoms.
- OSA is frequently overlooked in patients with psychiatric conditions and polysubstance use.
- Untreated OSA can exacerbate mental health issues and substance abuse behaviors.
Abstract:
Obstructive sleep apnea (OSA), depression, and substance abuse problems share similar symptomatology and have significant interplay. An underlying diagnosis of OSA can often be overlooked in patients with significant psychiatric illness and polysubstance use. Pediatric OSA is often associated with adenotonsillar hypertrophy and frequently requires surgical intervention for resolution of symptoms. Untreated OSA can worsen mental status and encourage polysubstance abuse as a form of self-medication. Proper identification and management of OSA plays an important role in treating psychiatric conditions. We report a 16-year-old with major depressive disorder (MDD), suicide attempts, polysubstance use disorder, and severe OSA admitted to an inpatient psychiatric facility. History included sleep and mood disturbances started at age 12. Patient presented with apnea-hypopnea index greater than 50 and started on bilevel-positive airway pressure (BiPAP) prior to admission. Management of OSA led to significant improvement of MDD, insomnia, and polysubstance abuse. OSA can often be overlooked in patients with MDD or substance abuse. Among adolescent patients with poorly managed psychiatric conditions, significant sleep disturbances, and polysubstance abuse, providers should maintain a high degree of suspicion for OSA, as its proper management will aid in the management of the other conditions.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sleep Apnea
The condition is more prevalent among...
CNS Depressants: Barbiturates and Benzodiazepines
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antidepressant Drugs: MAOIs and Other Agents

